Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Sold by RTW Investments LP

RTW Investments LP lessened its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 1.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,645,703 shares of the company's stock after selling 30,000 shares during the quarter. Establishment Labs comprises about 1.7% of RTW Investments LP's holdings, making the stock its 24th largest holding. RTW Investments LP owned 9.45% of Establishment Labs worth $114,480,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Rice Hall James & Associates LLC increased its stake in shares of Establishment Labs by 10.7% in the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company's stock worth $34,326,000 after acquiring an additional 76,959 shares during the last quarter. Bamco Inc. NY increased its position in Establishment Labs by 13.6% during the third quarter. Bamco Inc. NY now owns 489,386 shares of the company's stock worth $21,176,000 after purchasing an additional 58,611 shares during the last quarter. William Blair Investment Management LLC raised its stake in Establishment Labs by 14.5% during the second quarter. William Blair Investment Management LLC now owns 481,572 shares of the company's stock worth $21,883,000 after purchasing an additional 60,848 shares during the period. Sofinnova Investments Inc. boosted its holdings in Establishment Labs by 204.1% in the 2nd quarter. Sofinnova Investments Inc. now owns 429,244 shares of the company's stock valued at $19,505,000 after purchasing an additional 288,082 shares during the last quarter. Finally, First Turn Management LLC purchased a new stake in shares of Establishment Labs in the 2nd quarter valued at approximately $16,812,000. Hedge funds and other institutional investors own 72.91% of the company's stock.

Establishment Labs Trading Down 5.4 %

NASDAQ ESTA traded down $2.38 on Thursday, reaching $41.79. The stock had a trading volume of 337,647 shares, compared to its average volume of 387,811. Establishment Labs Holdings Inc. has a 12-month low of $22.05 and a 12-month high of $60.12. The stock has a fifty day moving average price of $43.50 and a two-hundred day moving average price of $44.53. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -16.20 and a beta of 1.16. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94.

Analyst Ratings Changes

Several research firms have recently commented on ESTA. Stephens raised shares of Establishment Labs to a "strong-buy" rating in a research report on Monday. JPMorgan Chase & Co. reduced their target price on Establishment Labs from $61.00 to $50.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 7th. BTIG Research increased their price target on Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a report on Monday, October 14th. Finally, Citigroup raised their price objective on Establishment Labs from $45.00 to $50.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $60.60.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.